Neurology

Treatment of nonmotor symptoms: AAN report

 

The AAN Quality Standards subcommittee has issued its recommendations on the treatment of nonmotor symptoms in patients with Parkinson’s disease (Zesiewicz et al. Neurology 2010; 74: 924-931; free full text at www.neurology.org/cgi/reprint/74/11/924). Nonmotor symptoms addressed included sleep disorders (restless legs syndrome, periodic limb movements of sleep, excessive daytime somnolence, insomnia, REM sleep behaviour disorder), autonomic dysfunction (GI disorders, orthostatic hypotension, sexual dysfunction, urinary incontinence), fatigue and anxiety.

Read More

TOPICS:

Mitoxantrone in MS: AAN report

 

The AAN Therapeutics and Technology Assessment subcommittee has published its report on the safety and efficacy of mitoxantrone in multiple sclerosis, concluding that the risks of systolic dysfunction and therapy-related leukemia are higher than previously estimated (Marriott et al. Neurology 2010; 74: 1463-1470; free full text at www.neurology.org/cgi/reprint/74/18/1463).

Read More

TOPICS:

Troponin in intracerebral hemorrhage

 

REPORT FROM THE AAN, APRIL 10-17, 2010 – Several retrospective analyses have suggested that elevated troponin levels at admission are associated with higher mortality rates in patients following intracerebral hemorrhage (ICH) (Garrett et al. Neurocrit Care 2010; 12: 199-203; Hays & Diringer. Neurology 2006; 66: 1330-1334; Chung et al. J Korean Neurosurg Soc 2009; 45: 355-359. Free full text at www.jkns.or.kr/htm/fulltext.asp?no=0042009075).

Read More